Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy

Dexamethasone Clinical Trial

Official title:

Effect of Dexamethasone Adjuvant in Combined Supraclavicular Block and Suprascapular Block Versus Interscalene Block in Patients Undergoing Shoulder Arthroscopy

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06262893
• Other study ID #: Shoulder nerve blocks
• Status: Not yet recruiting
• Phase: N/A
• Start date: February 25, 2024
• Est. completion date: January 2026

Study information

• Verified date: February 2024
• Source: Assiut University
• Contact: Mohamed Ahmed
• Phone: 01151994269
• Email: mohamedelkhatib90[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study the investigators aim to compare the effect of the suprascapular- supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on analgesic effect during arthroscopic shoulder surgery, as postoperative pain scores ,postoperative consumption of analgesic rescue medications and diaphragmatic excursion assessment.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: January 2026
• Est. primary completion date: December 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• ASA status 1,2.

• Age 18 years or older

• Elective shoulder arthroscopic surgery under general anesthesia and nerve block performed preoperatively.

Exclusion Criteria:

• • Patient refusal

• Serious cardiac arrhythmias (including atrial fibrillation) or unstable coronary artery disease.

• Use of drugs that act on the autonomic nervous system (including ß- blockers).

• Coagulation disorders..

• Anatomical disorders and/or neuropathic disease.

• BMI above 40.

• History of substance abuse.

• Chronic use of psychotropic and/or opioid.

• History of psychiatric diseases needing treatment.

• Allergy to any drug in the study protocol.

• Failure of nerve block performed in the preoperative block room when tested prior to entering the operating room (i.e. lack of loss of sensation to ice at the shoulder incision level).

Related Conditions & MeSH terms

• Dexamethasone

Intervention

Procedure:
• Shoulder arthroscopy blocks
Effect of dexamethasone adjuvant in combined supraclavicular block and suprascapular block versus Interscalene block in patients undergoing shoulder arthroscopy.

Locations

Country	Name	City	State
Egypt	Assiut University	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative analgesia by visual analog scale (VAS).	The; primary outcome of this study will be to evaluate and compare between suprascapular-supraclavicular nerve block in association with dexamethasone to that of the interscalene brachial plexus block on postoperative analgesia by vas score during 24 h postoperatively ( 2h , 6h , 12h, 24h).; The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be').	24 hours
Secondary	Diaphragmatic excursion	Assessment of diaphragmatic excursion by ultrasound preoperatively and 1hour postoperatively	1hour postoperatively